Advanced Rectal Cancer Current Events | Advanced Rectal Cancer News | 8
|
| Page
8 of
105 |
2089 Results |
|
|
|
Sort By:
Page Views | Date |
NEW DIAGNOSTIC METHOD COULD IMPROVE DETECTION OF PROSTATE CANCER (p 1849)
A new diagnostic technique using colour Doppler with an ultrasound contrast agent is more effective than conventional systematic biopsy in diagnosing prostate cancer, conclude the authors of a research letter in this week's issue of THE LANCET. Prostate cancer detection is currently based on three diagnostic tests: serum prostate-specific antigen... view more... (2001-06-06)
Targeted agent shows promise in biliary cancer study
An experimental agent has shown promising results in people with advanced biliary cancer, according to a multi-institutional clinical trial led by cancer researchers at the Ohio State University. view more (2009-04-21)
International Study Suggests Carboplatin Could Be First-line Chemotherapy Drug For Ovarian Cancer
Results of an international study in this week's issue of THE LANCET suggest that the drug carboplatin could become a first-line chemotherapeutic agent for the treatment of ovarian cancer. Carboplatin was found to be less toxic, although it had no overall survival benefit, compared with other drugs assessed in the study. Ovarian cancer is the... view more... (2002-08-14)
Scottsdale Healthcare-TGen clinical trial results signal advances against skin cancer
Analyses of clinical trial results published today in the New England Journal of Medicine (NEJM) shows a potential new investigational therapy for advanced and metastatic basal cell skin cancer. view more (2009-09-03)
Germany: Colonoscopy prevents 15,000 cancer cases
Since 2002, statutory health insurances in Germany have offered an endoscopic examination of the colon (colonoscopy) free of charge for all insured persons from the age of 55. Germany was the first country to make nationwide endoscopic screening for bowel cancer a part of its statutory early cancer detection program. view more (2009-03-23)
Drug fends off kidney cancer progression
New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus (RAD001) significantly delays cancer progression in patients with metastatic kidney cancer whose disease had worsened on other treatments. view more (2008-05-19)
New blood marker may predict prostate cancer spread
Researchers report finding a new blood biomarker that enables close to 98 percent accuracy in predicting the spread of prostate cancer to regional lymph nodes. view more (2008-02-28)
Suicide Gene Combination Targets Breast Cancer
A new 'mix and match' cancer therapy is being unveiled at the British Endocrine Societies meeting in Birmingham today. view more (2000-03-07)
Advanced-stage ovarian cancer patients with BRCA live longer, may respond better to treatment
Two abstracts underscoring the importance of testing for BRCA1/2 mutations in women with ovarian cancer were presented at this week's Society of Gynecologic Oncologists 39th Annual Meeting on Women's Cancers, by researchers from The University of Texas M. D. Anderson Cancer Center. view more (2008-03-11)
University of Kent Appoints Leading Cancer Researcher
One of the UKˇ¦s leading cancer researchers, Professor Bill Gullick, is to become the University of Kent at Canterburyˇ¦s (UKC) new Chair in Cancer Biology from 1 January 2000. Currently Principal Scientist at the Imperial Cancer Research Fund (ICRF) Molecular Oncology Unit in Hammersmith, and Professor of Molecular Oncology at the Imperial... view more... (1999-11-15)
Study finds association between hepatitis B and pancreatic cancer
A new study has shown that evidence of past hepatitis B infection was twice as common in people with pancreatic cancer than in healthy controls. This study is the first to report an association between past exposure to the hepatitis B virus and pancreatic cancer, but researchers cautioned that more studies are necessary to evaluate the nature of... view more... (2008-09-30)
I-SPY trial offers key insights into locally advanced breast cancer
Scientists are reporting two findings that could influence the way researchers screen for, treat and assess prognosis for women with locally advanced breast cancer, an aggressive form of the disease. view more (2009-06-02)
Reactions to 'false-positive' prostate cancer screenings assessed
Men who get a "false-positive" prostate cancer result — an abnormal screening test followed by a biopsy indicating no evidence of cancer — appear more likely to worry about their subsequent risk of cancer and report more problems with sexual function compared to men with normal screening results, according to a University of... view more... (2007-03-05)
Sensitive and specific biomarker for early detection of prostate cancer identified
Scientists at a Maryland-based pharmaceutical company have preliminary evidence showing that a protein in the blood may prove to be a biomarker that is more sensitive and specific than current methods of early detection for prostate cancer. view more (2006-09-14)
tNOX serves as a serum marker for detection and monitoring of disease progression in prostate cancer
A team of researchers at Purdue University has found a protein in the blood that may prove to be more reliable than the standard prostate specific antigen (PSA) test in measuring the extent of prostate cancer. view more (2006-09-14)
Researchers announce new predictor for lung cancer treatment and survival
Research from the Ireland Cancer Center of University Hospitals of Cleveland has found a promising, novel biomarker that may be used to predict the survival of patients with advanced lung cancer and their response to treatment. view more (2006-06-06)
Age is an independent risk factor in young women with breast cancer
A 30 year old woman diagnosed with breast cancer has the same chance of survival as a 60 year old woman with breast cancer according to the latest findings presented today at the European Breast Cancer Conference (EBCC-5). view more (2006-03-23)
Racial and ethnic differences in colorectal cancer emphasize importance of screening
New research presented at the 72nd Annual Scientific Meeting of the American College of Gastroenterology emphasizes the importance of colorectal cancer (CRC) screening among racial and ethnic minorities, who have a higher incidence of colorectal cancer compared to Caucasians. view more (2007-10-15)
More than 6 months of hormone therapy doesn't help prostate cancer patients live longer
Prostate cancer patients treated with either radiation or surgery who use hormone therapy for longer than six months do not survive any longer than patients who use the treatment for a shorter amount of time. view more (2006-11-06)
High-dose vitamin C as a cancer therapy
Although early clinical studies conducted by Linus Pauling showed that high-dose vitamin C, given by intravenous and oral routes, may improve symptoms and prolong life in patients with terminal cancer, no benefits for cancer patients were seen when vitamin C therapy was administered orally in double-blind placebo-controlled studies at the Mayo... view more... (2006-03-28)
|
|
| Page
8 of
105 |
2089 Results |
|
|
|
Sort By:
Page Views | Date |
|
